Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients
- DOI
- 10.1038/jhh.2014.43
- Published
- 2014-06-26
- Container
- Journal of Human Hypertension
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/jhh.2014.43,
title = {Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients},
author = {L P Hasvold and J Bodegård and M Thuresson and J Stålhammar and N Hammar and J Sundström and D Russell and S E Kjeldsen},
year = {2014},
journal = {Journal of Human Hypertension},
doi = {10.1038/jhh.2014.43},
url = {https://doi.org/10.1038/jhh.2014.43}
}RIS
TY - JOUR TI - Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients AU - L P Hasvold AU - J Bodegård AU - M Thuresson AU - J Stålhammar AU - N Hammar AU - J Sundström AU - D Russell AU - S E Kjeldsen PY - 2014 JO - Journal of Human Hypertension DO - 10.1038/jhh.2014.43 UR - https://doi.org/10.1038/jhh.2014.43 ER -
APA
Hasvold, L. P., Bodegård, J., Thuresson, M., Stålhammar, J., Hammar, N., Sundström, J., Russell, D., & Kjeldsen, S. E. (2014). Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients. Journal of Human Hypertension. https://doi.org/10.1038/jhh.2014.43
Source records
- crossref · retrieved 2026-09-26T16:59:17.080Z